News
Methotrexate 25mg/mL; soln for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical ...
The study suggests a potential benefit of routine multidose methotrexate treatment for recurrent cases of ectopic pregnancy.
Methotrexate Injection is available as a 25mg/mL concentration in 2mL and 10mL glass vials. For more information call (888) 482-9522 or visit www.tevausa.com. Picked For You ...
The mechanisms by which methotrexate and intramuscular gold therapy act are complementary, but the combination of their respective pharmacokinetics and toxicity would predict that one would not ...
German drug maker Sandoz on Thursday announced a recall of two sizes of methotrexate injection vials sold under the Sandoz and Parenta brands because of the possible presence of glass flakes.
The FDA approved pegloticase (Krystexxa) injection coadministered with methotrexate, Horizon Therapeutics announced Friday. Pegloticase is currently the only FDA-approved medication used to reduce ...
A total of 152 participants were randomized 2:1 to run-in and treatment periods with oral methotrexate (15 mg/week) or placebo, followed by a 52-week treatment period of KRYSTEXXA (8-mg bi-weekly ...
A retrospective analysis of methotrexate (MTX) safety data found that injection of this disease-modifying anti-rheumatic drug (DMARD) was not superior to oral therapy in long-term treatment of ...
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today topline results from its MIRROR open-label study in which methotrexate with KRYSTEXXA® (pegloticase injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results